Skip to content
Aminoscope
← Research
Longevity

NAD injections: how to get them near you or online, and what the evidence really says

Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

Nadia Feldman8 min read
How people get NAD+ injections: a clinic near you or telehealth to your door — while oral precursors lead on evidenceclinic near meonline to your doorself-injection at homeevidence: oral precursors leadNAD+ INJECTIONS · ACCESS VS EVIDENCE

Type “NAD injections near me” into a search bar and you’ll get two kinds of answer: a map of local clinics, and a wall of telehealth sites promising vials shipped to your door. Both are selling the same idea — subcutaneous NAD+ you inject yourself, pitched as the convenient, lower-cost way to get the molecule without sitting through an IV drip. This page is about that access question: what these injections actually are, the realistic ways people get them, what the experience is like, and the part the booking page skips — that the convenience is layered on top of a therapy with no controlled human outcome trials. For the underlying biology and the IV version of the story, we link out rather than repeat them.

Subcutaneous

How NAD+ injections are given — self-injected, not infused

compounded telehealth/clinic kits

Compounded

Regulatory status: not an FDA-approved drug for this use

compounding-pharmacy product

0

Controlled outcome trials of injectable NAD+ for anti-aging/energy

PubMed

What a “NAD injection” actually is

A NAD+ injection is a small subcutaneous shot — the same kind of under-the-skin injection used for compounded GLP-1s or peptides — rather than the slow intravenous infusion sold at drip bars. The appeal is logistical: no clinic chair, no two-hour drip, and a per-dose price that undercuts an IV session. You receive a vial of compounded NAD+, syringes, and instructions, then dose yourself on a schedule the prescriber sets. Mechanically it’s a different delivery from the IV, but it’s aimed at the same target molecule. We cover what NAD+ is and why its level matters in the NAD+ precursors evidence review; here the focus is strictly the injection and how you get it.

Route 1 — “NAD injections near me”: the local clinic

The first route is the one the “near me” search is built for: a local longevity clinic, med-spa, or wellness practice that prescribes NAD+ injections and sends you home with a starter kit. You book an in-person consult, sometimes get a quick lab panel, and a clinician demonstrates the self-injection technique before you leave with vials. The draw is the hand-holding — a real person shows you how to draw and dose, and there’s a local address to call if something feels off.

The trade-off is cost and friction. A clinic visit usually carries a consult fee, the price often assumes you walk out with a multi-week supply, and the same practice will frequently cross-sell adjacent services — an IV add-on, a glutathione push, or a vitamin drip. You’re paying for proximity and in-person onboarding, not for a different or better molecule than the online route ships. If a “near me” clinic is your plan, treat the first visit as the moment to confirm it’s a licensed prescriber working with a legitimate compounding pharmacy, not just a storefront with a fridge.

Route 2 — NAD injections online: telehealth to your door

The second route skips the map entirely. A growing set of telehealth providers run the whole thing remotely: you fill out an intake form, a licensed clinician reviews it (sometimes by asynchronous message, sometimes a brief video call), and if approved, a compounding pharmacy ships the compounded NAD+ vials and supplies directly to your home on a recurring monthly plan. No clinic, no chair time, and often a lower headline price than the local kit — which is exactly why “NAD injections online” has become its own search.

This is the format most like the broader compounded-telehealth market: a flat monthly fee that bundles the medication, the clinician review, and shipping, with no insurance involved. We keep the provider-by-provider pricing for this route — and how it compares to IV and oral — in the NAD therapy cost guide, and a vetted, ranked comparison of the legitimate telehealth options in our best NAD+ therapy provider comparison. The convenience is real; the caveat is that “ships to your door” doesn’t upgrade the evidence behind what’s in the vial.

The practical reality: dosing, discomfort, and flushing

However you obtain it, the at-home experience is similar. Subcutaneous NAD+ is typically self-injected on a schedule the prescriber sets, often starting low and titrating up. The commonly reported downside is local: stinging or burning at the injection site and a warm, sometimes intense flushing sensation — the same flushing that forces IV NAD+ to be dripped slowly, just compressed into a single shot. People manage it by injecting slowly and keeping doses modest. None of this is a published incidence figure; it’s the consistent texture of self-reports and clinic guidance, and it’s worth knowing before your first dose so it isn’t alarming.

The bigger practical caveat is regulatory. NAD+ injections for anti-aging, energy, or recovery are compounded, not FDA-approved for those uses, and aren’t covered by insurance. Compounded means a pharmacy prepares the product rather than it being a manufactured, approved drug — which is exactly why purity, sterility, and dosing depend on the quality of the specific pharmacy in the chain. Sourcing from a real prescriber and a reputable compounder is the whole game.

The honest evidence frame: access is the easy part

Here is the part the “near me” convenience pitch sits on top of. Making NAD+ injections easier to get does nothing to change what they’ve been shown to do — and on controlled human outcomes, that’s very little. There is no controlled clinical trial demonstrating that injectable (or IV) NAD+ delivers the anti-aging, energy, or recovery benefits it’s marketed for; the single human study of an intravenous NAD+ infusion simply tracked the molecule and found it was cleared from the plasma quickly, measuring metabolism rather than any clinical outcome.[2] The injectable route inherits that same evidence gap.

The route that actually has the human trial data is the oral precursor one. In a randomized, placebo-controlled trial, chronic oral nicotinamide riboside (NR) was well-tolerated and effectively raised blood NAD+ in healthy middle-aged and older adults.[1]That’s the inversion worth internalizing: the cheapest, least “medical-feeling” format — a capsule — is the one with controlled trials behind its core claim, while the injectable you can now get shipped to your door is the one selling ahead of its data. (Even the oral precursors only prove they raise the biomarker, not that doing so extends healthspan — our precursors review walks that line.)

NAD+ by route: the injection is the convenient middle tier, but the controlled human evidence lives with the oral precursors.
RouteHow you access itWhat the evidence shows
Subcutaneous injection (this page)Clinic kit “near me” or telehealth shipped to your doorCompounded; no controlled outcome trial of injectable NAD+
IV infusionIn-clinic drip bar or mobile concierge visitNo controlled outcome trial; infused NAD+ cleared from plasma fast
Oral precursor (NR/NMN)Over-the-counter capsule, no clinician neededRCTs show it raises blood NAD+ — the route with the human data
NAD+ by route: the injection is the convenient middle tier, but the controlled human evidence lives with the oral precursors. Martens 2018 (PMID 29599478); Grant 2019 (PMID 31572171); access models per provider pricing, mid-2026.

How to decide what to do

If you specifically want the injectable experience, the choice between a “near me” clinic and an online telehealth service comes down to whether you value in-person onboarding or door-step convenience — not to any difference in the molecule or the evidence behind it. Either way, insist on a licensed prescriber and a reputable compounding pharmacy, and go in clear-eyed that you’re buying a convenience-and-compounding service whose outcome claims aren’t backed by controlled trials. If your real goal is simply the best-supported way to raise NAD+ for the least money and friction, the oral-precursor capsule is the defensible starting point. To weigh the formats yourself, our NAD+ format comparator lines them up on cost, convenience, and evidence, and the longevity evidence matrix grades NAD+ against other longevity interventions so you’re not paying outcome prices for biomarker-level proof.

The honest bottom line

NAD+ injections are the convenient middle of the NAD+ market: subcutaneous shots you give yourself, reachable through a local “near me” clinic kit or a telehealth service that mails them to your door. They’re compounded rather than FDA-approved, aren’t covered by insurance, and commonly sting or flush at the injection site. Most of all, easier access doesn’t change the underlying science: injectable NAD+ has no controlled human outcome trials, while oral NR/NMN precursors are the route with the randomized data showing they raise blood NAD+.[1] Get the convenience if you want it — but price it as convenience, and anchor the spend to where the evidence actually is.

Reviewed against primary sources by the Aminoscope desk

Sources

  1. [1] Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. PMID 29599478
  2. [2] Grant R, Berg J, Mestayer R, et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Front Aging Neurosci. PMID 31572171
  3. [3] Ashraf AR, Mackey TK, Vida RG, et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res. PMID 39509151

More in Longevity